Pelitinib-d6
CAS: 1325223-34-4
Ref. 3D-ADC22334
| 1mg | Nachfragen | |
| 5mg | Nachfragen | |
| 10mg | Nachfragen | |
| 25mg | Nachfragen | |
| 50mg | Nachfragen |
Produktinformation
Pelitinib-d6 is an anticancer drug that inhibits the activity of protein kinases, which are enzymes involved in cell cycle regulation and apoptosis. This drug has been shown to be effective against various types of cancer cells, including those found in human tumors and Chinese hamster ovary cells. Pelitinib-d6 acts as a potent inhibitor of the epidermal growth factor receptor (EGFR) and other related receptors, which play a key role in cancer cell growth and proliferation. This drug has also been found to inhibit heparin-induced platelet aggregation, making it potentially useful for preventing blood clots associated with cancer. Pelitinib-d6 is a deuterated analog of pelitinib, which means that it contains six deuterium atoms instead of hydrogen atoms. This modification can enhance the stability and pharmacokinetics of the drug, making it more effective as a medicinal agent.
Chemische Eigenschaften
Technische Anfrage zu: 3D-ADC22334 Pelitinib-d6
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
